5′‐Iodination of Solid‐Phase‐Linked Oligodeoxyribonucleotides by Kool, Eric T. & Miller, Gregory P.
UNIT 4.195′-Iodination of Solid-Phase-Linked
Oligodeoxyribonucleotides
This unit describes a method for converting the 5′-hydroxyl of CPG-bound oligodeoxyri-
bonucleotides to an iodo group. This procedure is useful when an electrophilic group is
desired in the terminal 5′-position of an oligodeoxyribonucleotide. Because the iodo
group is an efficient leaving group in SN2 displacement reactions, its introduction at the
5′-position allows for facile ligation to small molecules or macromolecules containing a
strongly nucleophilic group. Additionally, 5′-iodo oligonucleotides can easily be con-
verted to a wide variety of other functional groups.
Two protocols are described in this unit. For both procedures, an oligonucleotide is
prepared on an automated DNA synthesizer (see APPENDIX 3C) and is then iodinated
in-column (i.e., while still protected and immobilized on the CPG resin in the column).
The first method (see Basic Protocol) describes a manual procedure performed by adding
reagents to the column after it is removed from the synthesizer. The second method (see
Alternate Protocol) provides an automated method performed by programming the
synthesizer to perform the same iodination reaction. The manual procedure is suitable for
most applications, while the automated method may be preferable for carrying out
multiple iodination reactions.
CAUTION: All chemicals must be used in a fume hood by qualified individuals equipped
with laboratory coats, safety glasses, and gloves.
BASIC
PROTOCOL
MANUAL PROCEDURE FOR 5′-IODINATION OF OLIGODEOXYRIBO-
NUCLEOTIDES ON A SOLID SUPPORT
This protocol outlines a method to convert the 5′-hydroxyl on protected CPG-bound
oligodeoxyribonucleotides to an iodo group (Fig. 4.19.1). In this procedure, an iodination
solution is passed between two syringes fitted to the ends of a DNA synthesis column
containing the attached oligodeoxyribonucleotide, converting the 5′-hydroxyl to an iodo
group. The 5′-iodo-modified oligodeoxyribonucleotide can subsequently be cleaved and
deprotected using 28% aqueous NH4OH.
Materials
Anhydrous N,N-dimethylformamide (DMF)
Iodination solution (see recipe)
Methylene chloride (CH2Cl2)
28% (v/v) ammonium hydroxide (NH4OH)
DNA synthesizer (e.g., ABI; see APPENDIX 3C)
0.2 to 10 µmol DNA synthesis column with long-chain alkylamine controlled-pore
glass (CPG) support
1- and 10-mL syringes
Shaker, rocker, or other agitating device
C18 reversed-phase HPLC column (UNIT 10.5)
Speedvac evaporator
Additional reagents and equipment for oligonucleotide synthesis (Chapters 3 and 4
and APPENDIX 3C) and reversed-phase HPLC (UNIT 10.5)
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Synthesize oligonucleotide and obtain control sample
1. Using a DNA synthesizer, synthesize 0.2 to 10 µmol of CPG-bound protected
oligodeoxyribonucleotide with the 5′-O-(4,4′-dimethoxytrityl) group removed
(DMTr-OFF; see APPENDIX 3C).
2. Open DNA synthesis column, remove and set aside ∼1 mg of resin, then close column.
This sample of the resin will be cleaved and deprotected without undergoing the iodination
reaction and thus can be used as an HPLC reference to determine the retention time of the
starting material and estimate the retention time of the 5′-iodinated product.
Dehydrate resin
3. Attach an empty 1.0-mL syringe to one end of the DNA synthesis column. To the
other end, attach a 1.0-mL syringe filled with anhydrous DMF.
4. Slowly push DMF through column to the other syringe.
This step should remove any water that may be adsorbed to the resin that would otherwise
react with the water-sensitive iodination reagent.
Iodinate oligodeoxyribonucleotide
5. Remove the DMF-filled syringe and quickly replace with a 1.0-mL syringe filled with
iodination solution.
6. Push iodination solution back and forth between the two syringes several times.
7. Seal the junctions between the column and the syringes with Parafilm to prevent
leakage.
8. Put on shaker, rocker, or other agitating device for 15 to 20 min at room temperature.
If the 5′-end of the oligonucleotide contains a bulky group, it may be desirable to increase
the reaction time (see Critical Parameters and Troubleshooting for details).
9. Unwrap the column and use the syringes to remove the iodination solution from the
column.
10. Using a 10-mL syringe, push 5 to 10 mL DMF through the column, followed by a
few milliliters of CH2Cl2. Blow-dry beads using air.
The CH2Cl2 is not mandatory, but it facilitates drying of the CPG beads, making it easier
to remove them from the column.
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Figure 4.19.1 Iodination of solid-phase-linked oligodeoxyribonucleotides. Abbreviations: B1 and
B2, thymine and/or N-protected nucleobases; CPG, long-chain alkylamine controlled-pore glass
(resin).
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Cleave and deprotect iodinated deoxyribonucleotide
11. Open column and transfer beads to a sealed vial for deprotection.
12. Cleave and deprotect the iodinated product and the sample of starting material (from
step 2) by soaking each resin in 28% NH4OH (∼1 mL for 1-µmol column) at room
temperature for 18 to 24 hr.
13. Remove ammoniacal solution, rinse beads twice with small portions (e.g., 0.25 mL
for 1-µmol column) of deionized water, combine portions, and evaporate liquids in
a Speedvac evaporator.
14. Analyze purity by HPLC using a C18 reversed-phase column (UNIT 10.5).
ALTERNATE
PROTOCOL
AUTOMATED PROCEDURE FOR 5′-IODINATION OF OLIGODEOXYRIBO-
NUCLEOTIDES ON A SOLID SUPPORT
This protocol involves the use of a DNA synthesizer to perform the same iodination
reaction described in the Basic Protocol. The advantage of this automated procedure is
that the iodination reaction can be conveniently run on the DNA synthesizer as a 15-min
procedure following DNA synthesis. Depending on the number of columns on the
particular synthesizer, multiple reactions may be run simultaneously. Although the
iodination reagent is not harmful to the synthesizer, the reagent must be filtered prior to
use to ensure that no particulates clog the lines. Because of this additional step, it is often
more convenient to use the manual procedure if only one or two iodination reactions will
be performed. If multiple reactions are to be performed, the automated procedure is
generally faster and more convenient.
Additional Materials (also see Basic Protocol)
Glass wool or line filter (e.g., preparation and delivery line filter from ABI)
Empty DNA synthesis column (e.g., 1000-Å CPG column; ABI)
10-mL syringes
Clean, oven-dried phosphoramidite bottle compatible with synthesizer
Reagent bottle compatible with synthesizer, filled with anhydrous DMF
Synthesize oligonucleotide
1. Using a DNA synthesizer, synthesize 0.2 to 10 µmol CPG-bound protected oligode-
oxyribonucleotide with the 5′-O-DMTr group removed (see APPENDIX 3C).
Some resin (≤1 mg) may be removed at this point to use as a reference in HPLC.
Filter iodination solution for use in synthesizer
2. Filter iodination solution under anhydrous conditions as follows. Insert a small filter
or glass wool into an empty DNA synthesis column. Take up iodination solution in
a 5- or 10-mL syringe, and attach it to the column/filter. Attach another syringe to
the opposite end of the column. Push solution through column/filter into the opposite
syringe.
Generally, each reaction requires ≤1 mL of iodination solution.
The Preparation and Delivery Line Filter from ABI is the ideal size and shape to fit into a
1000-Å ABI CPG column.
If the solution contains a large quantity of particulates, the filter may become clogged. If
this happens, it may be necessary to remove the syringes (while making sure to minimize
exposure to the air) and wash the filter. To wash it, simply push dry DMF through the column
filter in the opposite direction from that in which the iodination solution was flowing.
The above filtration system is only one of a variety of ways that the filtration can be
performed.
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3. Attach a needle to the syringe containing the iodination solution.
4. Inject the iodination solution into an oven-dried and septum-sealed phosphoramidite
bottle.
Prepare synthesizer for iodination reaction
5. Write an iodination procedure for the DNA synthesizer containing the following
steps:
a. Rinse beads with anhydrous DMF.
b. Send iodination solution to column.
c. Wait (5 min).
d. Flush iodination solution to waste.
e. Send iodination solution to column.
Table 4.19.1 IodoCycle Program for ABI 392 and 394
Synthesizersa
Step Function Time (sec)
1 Begin
2 Prep DMF 15
3 DMF to waste 4
4 DMF to column 15
5 Reverse flush 10
6 Block flush 4
7 Phos prep 3
8 Iodo to column 20
9 DMF to waste 3
10 Block flush 4
11 Wait 300
12 Reverse flush 10
13 Iodo to column 20
14 DMF to waste 3
15 Block flush 4
16 Wait 300
17 DMF to column 15
18 Flush to waste 10
19 DMF to column 20
20 Flush to waste 10
21 DMF to column 20
22 Reverse flush 10
23 Block flush 4
24 CH3CN to waste 3
25 CH3CN to column 20
26 Reverse flush 10
27 CH2Cl2 to waste 3
28 CH2Cl2 to column 20
29 Reverse flush 10
30 Block flush 4
31 End
aModified from Miller and Kool (2002) with permission from the American
Chemical Society.
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f. Wait (5 min).
g. Rinse with anhydrous DMF.
An example of a functional procedure for ABI 392 and 394 synthesizers is shown in Table
4.19.1.
6. Install the iodination reagent into one of the phosphoramidite positions and install a
bottle of anhydrous DMF into one of the reagent positions on the DNA synthesizer.
7. Edit sequence: enter a single base as the sequence.
If this is not done, the iodination cycle will repeat itself for each base in the sequence.
Iodinate oligodeoxyribonucleotide
8. Start synthesis.
Due to differences between synthesizers, it is recommended that the column be observed
while the cycle is run the first few times to make sure the “iodination solution to column”
and “wash” sequences are of the correct length of time. A period of 20 to 30 sec for
“iodination solution to column” should be sufficient to completely fill the columns on an
ABI 392 or 394 synthesizer.
Cleave and deprotect iodinated deoxyribonucleotide
9. After the synthesis is complete, transfer the CPG resin to a sealed vial. Cleave and
deprotect the iodinated product by soaking the resin in 28% NH4OH (∼1 mL for
1-µmol column) at room temperature for 18 to 24 hr.
10. Remove iodination solution and DMF from synthesizer. To ensure that the iodination
reagent does not damage or contaminate the synthesizer, replace the iodination
reagent bottle with one containing anhydrous DMF and use the manual functions to
briefly rinse the lines.
The unused iodination solution can be stored in the phosphoramidite bottle (see recipe for
storage conditions).
11. Analyze purity using HPLC with a C18 reversed-phase column (UNIT 10.5).
REAGENTS AND SOLUTIONS
Use deionized, distilled water in all recipes and protocol steps. For common stock solutions, see
APPENDIX 2A; for suppliers, see SUPPLIERS APPENDIX.
Iodination solution
0.226 g (0.5 mmol) methyltriphenoxyphosphonium iodide [(PhO)3PCH3I;
Aldrich; 0.5 M final]
0.85 ml anhydrous N,N-dimethylformamide (DMF)
Prepare fresh or store up to 3 months at –70°C
If the solution will be used on a DNA synthesizer, it should be filtered before use (see Alternate
Protocol).
(PhO)3PCH3I reacts quickly with water and is light sensitive. Minimize exposure of the
reagent to the atmosphere while weighing, and promptly flush the vial and the original
reagent bottle with N2 or argon when finished.
It is convenient to prepare the iodination solution during oligonucleotide synthesis. If the
solution will be used within a few hours of its preparation, there is no need to protect it from
light. If the iodination solution has been frozen, always refilter (see Alternate Protocol, step
2) after thawing.
(PhO)3PCH3I is often the consistency of mud or a thick oil. Although this makes it more
difficult to manipulate, it generally still works well.
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COMMENTARY
Background Information
In 1997, Xu and co-workers described a
DNA-ligation method which allowed for the
efficient ligation of a 5′-iodo-modified oligode-
oxyribonucleotide with a 3′-phosphorothioated
oligonucleotide (Xu and Kool, 1997). In the
presence of a complementary template, ligation
proceeded efficiently under mild conditions.
The product of this ligation method is an oli-
gonucleotide identical to natural DNA with the
exception that one oxygen atom in the phos-
phodiester backbone is replaced by a sulfur
atom; it therefore retains most of the chemical
properties of natural DNA (Xu and Kool,
1998). The 5′-iodo-modified oligomers were
prepared on a DNA synthesizer using a pre-
viously synthesized 5′-iodo-dT phos-
phoramidite. Unfortunately, 5′-iodo-modified
phosphoramidites are time-consuming and ex-
pensive to synthesize, so the utility of this
ligation system was significantly limited.
It was subsequently found that the 5′-iodo-
oligodeoxyribonucleotides are in fact accessi-
ble via a much simpler, more direct route
(Miller and Kool, 2002). The protocols de-
scribed in this unit are based on this new ap-
proach, in which 5′-iodination is carried out
directly on the DNA column, before deprotec-
tion and cleavage. The protecting groups used
on the DNA bases and backbone effectively
prevent the very reactive (PhO)3PCH3I from
reacting at any site other than the 5′-hydroxyl.
This is true when using both Glen Research’s
Sterling 2-cyanoethyl (CE) phosphoramidites
(5′-DMTr-dABz, 5′-DMTr-dCBz, and 5′-DMTr-
dGi-Bu) or their Ultramild CE phosphoramidites
(5′-DMTr-dAi-Bu or 5′-DMTr-dAAcOPh,  5′-
DMTr-dGAcOPh-i-Pr, and 5′-DMTr-dCAc). Also,
it was found that when deprotection and cleav-
age are carried out at room temperature for 24
hr, very little hydrolysis of the iodo group
occurs. This new method of iodinating the 5′-
end of oligodeoxyribonucleotides effectively
makes the 5′-iodo/3′-phosphorothioate ligation
system accessible to anyone with access to
synthetic DNA. Unfortunately, it was found
that  both 2′-O-tert-butyldimethylsilyl
(TBDMS) and 2′-O-triisopropylsilyloxy-
methyl (TOM) protecting groups on protected
oligoribonucleotides are cleaved by both
(PhO)3PCH3I and another iodinating system,
PPh3/I2/imidazole in DMF (Kool and Miller,
unpub. observ.).
In addition to their usefulness in DNA liga-
tion reactions, the 5′-iodo oligomers are also
good intermediates for making other types of
5′-modifications. The 5′-iodo group is easily
converted to thiols, amines, azides, thioethers,
thiocyanates, and selenides while the oligomer
is still attached to resin (Kool and Miller, unpub.
observ.). 5′-Thiols and amines are convenient
handles for attaching isothiocyanates, succin-
imidyl esters, maleimides, iodoacetamides, and
other commercially available labels. Alterna-
tively, thiol-containing moieties will react di-
rectly with 5′-iodo oligomers, forming very
stable thioethers.
Critical Parameters and
Troubleshooting
The most important key to success in run-
ning this reaction is to keep the iodination
reagent anhydrous. The large excess of reagent
called for in this protocol should temper this
potential problem. Care should nevertheless be
taken to minimize the amount of time the re-
agent is exposed to the air, and the reagent and
iodination solution should always be stored
under an inert gas.
Another important point is that the reaction
time may need to be increased when bulkier
groups are in the 5′-position. For example,
when pyrene is in the 5′-position, the iodination
reaction requires ∼25 min for completion. Ad-
ditionally, if there is a modified base containing
a strong nucleophile near the 5′-end, it may
displace the iodo group, cyclizing the oligomer
either during synthesis or during deprotection.
This is often observed when the 5′-base is a
purine, in which the N3 nitrogen attacks the
5′-carbon, resulting in some cyclized material
(Dimitrijevich et al., 1979). This cyclized
byproduct may be hydrolyzed back to the 5′-
hydroxy starting material upon treatment with
NH4OH.
Anticipated Results
The hydrophobicity of the iodo group allows
for easy separation of 5′-modified oligodeoxy-
ribonucleotides from their 5′-hydroxy starting
materials via reversed-phase HPLC (UNIT 10.5).
For example, using a gradient of 0% to 20%
CH3CN in 50 mM triethylammonium acetate
(TEAA), pH 7.0, over a 20-min period to elute
the crude reaction mixture from an analytical
C18 reversed-phase column, iodinated trimers
elute 5 min later than their corresponding start-
ing materials, while iodinated 13-mers elute
∼2 min after their respective starting materials
(see Fig. 4.19.2). A chromatogram of the de-
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protected 5′-hydroxyl starting material should
therefore give an indication of when the iodi-
nated product will come off of the column.
Also, knowledge of the starting material reten-
tion time allows for calculation of percent con-
version to the iodinated product. Electrospray
ionization (ESI) mass spectrometry (UNIT 10.2)
should be used to verify the identity of the
product.
The success of this iodination reaction ap-
pears to depend on the identity of the 5′-base,
but not the overall base composition, of a par-
ticular oligomer. Generally, 5′-pyrimidines af-
ford the highest yields because they do not
cyclize as easily as purines. Yields of 70% to
90% are typical for pyrimidines and 50% to
80% for purines, based on total integration of
HPLC chromatograms (Miller and Kool, 2002,
and unpub. observ.). Because the starting ma-
terial will contain failure sequences from in-
complete phosphoramidite coupling during oli-
gomer synthesis, HPLC chromatograms will
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Figure 4.19.2 RP-HPLC profiles of 5′-d(NGTAGGCAAGAGT) before and after 5′-iodination. From
top to bottom, N = T, C, A, and G, respectively. Reprinted from Miller and Kool (2002) with permission
from the American Chemical Society.
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contain multiple peaks. However, a single pre-
dominant product peak with a longer retention
time should be observed when using a reversed-
phase column.
Time Considerations
The manual procedure described in the Ba-
sic Protocol can be completed in less than an
hour. The automated procedure requires more
time to set up the reactions, but once the reagent
and synthesizer are prepared, many reactions
can be performed quickly. For example, if a
4-column synthesizer is used with a 15-min
iodination cycle, 16 reactions can be performed
per hour.
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